Limoneira Co (NASDAQ:LMNR - Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $13.39 and traded as high as $13.95. Limoneira shares last traded at $13.76, with a volume of 47,082 shares.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on LMNR shares. Weiss Ratings restated a "sell (d)" rating on shares of Limoneira in a research report on Wednesday, June 24th. Lake Street Capital decreased their price objective on Limoneira from $19.00 to $18.00 and set a "buy" rating for the company in a research report on Wednesday, June 10th. Finally, HC Wainwright downgraded Limoneira to a "buy" rating in a research note on Wednesday, June 10th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Limoneira presently has an average rating of "Hold" and an average price target of $18.00.
Read Our Latest Stock Analysis on LMNR
Limoneira Price Performance
The company has a market cap of $249.47 million, a price-to-earnings ratio of -6.04 and a beta of 0.30. The company's 50 day moving average price is $13.18 and its 200 day moving average price is $13.39. The company has a current ratio of 1.68, a quick ratio of 1.53 and a debt-to-equity ratio of 0.61.
Limoneira (NASDAQ:LMNR - Get Free Report) last issued its quarterly earnings results on Tuesday, June 9th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.08). The firm had revenue of $23.93 million for the quarter, compared to analyst estimates of $21.42 million. Limoneira had a negative return on equity of 13.94% and a negative net margin of 30.50%. Equities research analysts forecast that Limoneira Co will post -0.47 earnings per share for the current year.
Hedge Funds Weigh In On Limoneira
A number of large investors have recently modified their holdings of LMNR. BNP Paribas Financial Markets lifted its stake in shares of Limoneira by 64.8% in the second quarter. BNP Paribas Financial Markets now owns 1,699 shares of the company's stock valued at $27,000 after purchasing an additional 668 shares during the period. Bank of America Corp DE grew its position in Limoneira by 5.5% during the first quarter. Bank of America Corp DE now owns 16,559 shares of the company's stock worth $222,000 after buying an additional 859 shares during the period. Flax Pond Capital LLC grew its position in Limoneira by 0.7% during the first quarter. Flax Pond Capital LLC now owns 171,132 shares of the company's stock worth $2,297,000 after buying an additional 1,224 shares during the period. American Century Companies Inc. increased its holdings in Limoneira by 3.8% in the second quarter. American Century Companies Inc. now owns 36,690 shares of the company's stock valued at $574,000 after buying an additional 1,359 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in Limoneira by 5.7% in the third quarter. Russell Investments Group Ltd. now owns 25,614 shares of the company's stock valued at $380,000 after buying an additional 1,380 shares in the last quarter. 64.35% of the stock is owned by hedge funds and other institutional investors.
About Limoneira
(
Get Free Report)
Limoneira Company NASDAQ: LMNR, founded in 1893 and based in Santa Paula, California, is a diversified agribusiness and real estate enterprise. As one of the oldest citrus producers in the United States, Limoneira has built a reputation for cultivating and marketing high-quality citrus fruits, avocados and specialty crops. The company's vertically integrated model encompasses farming, packing, processing and marketing activities designed to deliver fresh produce to domestic and international markets.
In its agricultural operations, Limoneira specializes in lemons, oranges and avocados, employing modern irrigation, harvesting and packing technologies to maintain consistent product quality and supply.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Limoneira, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Limoneira wasn't on the list.
While Limoneira currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
